Abstract
Nitric oxide (NO) is a pivotal signaling messenger in the cardiovascular system. NO participates in regulatory functions including control of hemostasis, fibrinolysis, platelet and leukocyte interactions with the arterial wall, regulation of vascular tone, proliferation of vascular smooth muscle cells, and homeostasis of blood pressure. Diminished NO bioavailability and abnormalities in NO-dependent signaling are among central factors of vascular disease, although it is unclear whether this is a cause of, or result of endothelial dysfunction or both pathogenic events. Disturbances in NO bioavailability have been linked to cause endothelial dysfunction, leading to increased susceptibility to atherosclerotic lesion progression, hypertension, hypercholesterolemia, diabetes mellitus, thrombosis and stroke.
Similar content being viewed by others
References
Atkins, G. B. and Jain, M. K., Role of krüppel-like transcription actors in endothelial biology. Circ. Res., 100, 1686–16895 (2007).
Boon, R. A., Fledderus, J. O., Volger, O. L., van Wanrooij, E. J., Pardali, E., Weesie, F., Kuiper, J., Pannekoek, H., ten Dijke, P., and Horrevoets, A. J., KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1. Arterioscler. Thromb. Vasc. Biol., 27, 532–539 (2007).
Bouhlel, M. A., Staels, B., and Chinetti-Gbaguidi, G., Peroxisome proliferator-activated receptors—from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease. J. Intern. Med., 263, 28–42 (2008).
Cao, S., Yao, J., and Shah, V., The proline-rich domain of dynamin-2 is responsible for dynamin-dependent in vitro potentiation of endothelial nitric-oxide synthase activity via selective effects on reductase domain function. J. Biol. Chem., 278, 5894–5901 (2003).
D’Armiento, F. P., Bianchi, A., De Nigris, F., Capuzzi, D. M., D’Armiento, M. R., Crimi, G., Abete, P., Palinski, W., Condorelli, M., and Napoli, C., Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classical risk factors for atherosclerosis. Stroke, 32, 2472–2479 (2001).
de Nigris, F., Lerman, A., Ignarro, L. J., Ignarro-Williams, S., Sica, V., Baker, A. H., Lerman, L. O., Geng, Y. J., and Napoli, C., Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends. Mol. Med., 9, 351–359 (2003).
Dekker, R. J., Boon, R. A., Rondaij, M. G., Kragt, A., Volger, O. L., Elderkamp, Y. W., Meijers, J. C., Voorberg, J., Pannekoek, H., and Horrevoets, A. J., KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood, 107, 4354–4363 (2006).
Dekker, R. J., van Thienen, J. V., Rohlena, J., de Jager, S. C., Elderkamp, Y. W., Seppen, J., de Vries, C. J., Biessen, E. A., van Berkel, T. J., Pannekoek, H., and Horrevoets, A. J., Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am. J. Pathol., 167, 609–618 (2005).
Doughan, A. K., Harrison, D. G., and Dikalov, S. I., Molecular mechanisms of angiotensin II mediated mitochondrial dysfunction. linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res., 102, 488–496 (2008).
Fledderus, J. O., van Thienen, J. V., Boon, R. A., Dekker, R. J., Rohlena, J., Volger, O. L., Bijnens, A. P., Daemen, M. J., Kuiper, J., van Berkel, T. J., Pannekoek, H., and Horrevoets, A. J., Prolonged shear stress and KLF2 suppress constitutive pro-inflammatory transcription through inhibition of ATF2. Blood, 109, 4249–4257 (2007).
Garcia-Cardena, G., Fan, R., Shah, V., Sorrentino, R., Cirino, G., Papapetropoulos, A., and Sessa, W. C., Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature, 392, 821–824 (1998).
Goodwin, B. L., Solomonson, L. P., and Eichler, D. C., Argininosuccinate synthase expression is required to maintain nitric oxide production and cell viability in aortic endothelial cells. J. Biol. Chem., 279, 18353–18360 (2004).
Goya, K., Sumitani, S., XU, X., Kitamura, T., Yamamoto, H., Kurebayashi, S., Saito, H., Kouhara, H., Kasayama, S., and Kawase, I., Peroxisome proliferator-activated receptor α agonists increase nitric oxide synthase expression in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol., 24, 658–663 (2004).
Hayashi, T., Juliet, P. A., Miyazaki, A., Ignarro, L. J., and Iguchi, A., High glucose downregulates the number of caveolae in monocytes through oxidative stress from NADPH oxidase: Implications for atherosclerosis. Biochim. Biophys. Acta., 1772, 364–372 (2007).
Ignarro, L. J., Cirino, G., Casini, A., and Napoli, C., Nitric oxide as a signaling molecule in the vascular system: An overview. J. Cardiovasc. Pharmacol., 34, 879–886 (1999).
Ignarro, L. J., Napoli, C., and Loscalzo, J., Nitric oxidedonating compounds and cardiovascular agents modulating the bioactivity of nitric oxide: An overview. Circ. Res., 90, 21–28 (2002).
Ignarro, L. J. and Napoli, C., Novel features on nitric oxide, endothelial nitric oxide synthase and atherosclerosis. Curr. Atheroscler. Rep., 6, 278–287 (2004).
Israelian-Konaraki, Z. and Reaven, P. D., Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications. Cardiol Rev., 13, 240–246 (2005).
Lavi, S., Yang, E. H., Prasad, A., Mathew, V., Barsness, G. W., Rihal, C. S., Lerman, L. O., and Lerman, A., The interaction between coronary endothelial dysfunction, local oxidative stress, and endogenous nitric oxide in humans. Hypertension, 51, 127–133 (2008).
Lim, E. J., Smart, E. J., Toborek, M., and Hennig, B., The role of caveolin-1 in PCB77-induced eNOS phosphorylation in human-derived endothelial cells. Am. J. Physiol. Heart. Circ. Physiol., 293, H3340–H3347 (2007).
Lin, Z., Kumar, A., Senbanerjee, S., Staniszewski, K., Parmar, K., Vaughan, D. E., Gimbrone, M. A. Jr, Balasubramanian, V., Garcia-Cardena, G., Jain, M. K., Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ. Res., 96, e48–e57 (2005).
Liu, V. W. T. and Huang, P. L., Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc. Res., 77, 19–29 (2008).
Maniatis, N. A., Brovkovych, V., Allen, S. E., John, T. A., Shajahan, A. N., Tiruppathi, C., Vogel, S. M., Skidgel, R. A., Malik, A. B., and Minshall, R. D., Novel mechanism of endothelial nitric oxide synthase activation mediated by caveolae internalization in endothelial cells. Circ. Res., 99, 870–877 (2006).
Napoli, C., de Nigris, F., Williams-Ignarro, S., Pignalosa, O., Sica, V., and Ignarro, L. J., Nitric oxide and atherosclerosis: An update. Nitric Oxide, 15, 265–279 (2006).
Napoli, C. and Ignarro, L. J., Nitric oxide and atherosclerosis. Nitric Oxide, 5, 88–97 (2001).
Napoli, C. and Ignarro, L. J., Nitric oxide-releasing drugs. Annu. Rev. Pharmacol. Toxicol., 43, 97–123 (2003).
Napoli, C. and Ignarro, L. J., Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis. J. Clin. Pathol., 60, 341–344 (2007).
Napoli, C., Lerman, L. O., De Nigris, F., Loscalzo, J., and Ignarro, L. J., Glyoxidized low-density lipoprotein down regulates endothelial nitric oxide synthase in human coronary cells. J. Am. Coll. Cardiol., 40, 1515–1522 (2002).
Napoli, C. and Lerman, L. O., Involvement of oxidation-sensitive mechanisms in the cardiovascular effects of hypercholesterolemia. Mayo Clin. Proc., 76, 619–631 (2001).
Napoli, C., Paterno, R., Faraci, F. M., Taguchi, H., Postiglione, A., and Heistad, D. D., Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits. Stroke, 28, 2266–2272 (1997).
Napoli, C., Witztum, J. L., De Nigris, F., Palumbo, G., D’Armiento, F. P., and Palinski, W., Intracranial arteries of human fetuses are more resistant to hypercholesterolemia-induced fatty streak formation than extracranial arteries. Circulation, 99, 2003–2010 (1999).
Parmar, K. M., Larman, H. B., Dai, G., Zhang, Y., Wang, E. T., Moorthy, S. N., Kratz, J. R., Lin, Z., Jain, M. K., Gimbrone, M. A. Jr, and Garcia-Cardena, G., Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J. Clin. Invest., 116, 49–58 (2006).
Parmar, K. M., Nambudiri, V., Dai, G., Larman, H. B., Gimbrone, M. A. Jr, and Garcia-Cardena, G., Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J. Biol. Chem., 280, 26714–26719 (2005).
Rabelink, T. J. and Luscher, T. F., Endothelial Nitric Oxide Synthase: Host defense enzyme of the endothelium? Arterioscler. Thromb. Vasc. Biol., 26, 267–271 (2006).
Schiffrin, E. L., Oxidative stress, nitric oxide synthase, and superoxide dismutase: A matter of imbalance underlies endothelial dysfunction in the human coronary circulation. Hypertension, 51, 31–32 (2008).
Sen-Banerjee, S., Lin, Z., Atkins, G. B., Greif, D. M., Rao, R. M., Kumar, A., Feinberg, M. W., Chen, Z., Simon, D. I., Luscinskas, F. W., Michel, T. M., Gimbrone, M. A. Jr, Garcia-Cardena, G., and Jain, M. K., KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med., 199, 1305–1315 (2004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Napoli, C., Ignarro, L.J. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch. Pharm. Res. 32, 1103–1108 (2009). https://doi.org/10.1007/s12272-009-1801-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-1801-1